Expression of calbindin D28k in the dopaminergic mesotelencephalic system in embryonic and fetal human brain

Journal of Comparative Neurology

Volumn 429, Issue 1, 2001, Pages 45-58

  Verney, Catherine ^a,c   Zecevic, Nada ^b   Ezan, Pascal ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Calretinin; Colocalization; Retrorubral area; Substantia nigra; Tyrosine hydroxylase; Ventral tegmental area

Indexed keywords

CALBINDIN; TYROSINE 3 MONOOXYGENASE;

AMYGDALOID NUCLEUS; ARTICLE; BRAIN TISSUE; CELL DEATH; CELL MIGRATION; DOPAMINERGIC SYSTEM; EMBRYO; FETUS; HUMAN; IMMUNOREACTIVITY; MESENCEPHALON; NERVE CELL; NORMAL HUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELENCEPHALON; TISSUE DISTRIBUTION;

AXONS; BRAIN TISSUE TRANSPLANTATION; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL DEATH; CELL MOVEMENT; DOPAMINE; FETAL TISSUE TRANSPLANTATION; FETUS; HUMANS; NEURAL PATHWAYS; NEURONS; PARKINSON DISEASE; PERIAQUEDUCTAL GRAY; SUBSTANTIA NIGRA; TELENCEPHALON; VENTRAL TEGMENTAL AREA;

EID: 0035218465     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9861(20000101)429:1<45::AID-CNE4>3.0.CO;2-J     Document Type: Article

References (67)

1. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: Lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice
2. First trimester of the human nigrostriatal dopamine system
3. Development of the brain stem in the rat: V. Thymidine-radiographic study of the time of origin of neurons in the midbrain tegmentum
4. Calcium-binding proteins: Selective markers of nerve cells
5. Molecular anatomy of the development of the human substantia nigra
6. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse
7. Ontogeny of the striatal neurons expressing neuropeptide genes in the human fetus and neonate
8. Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: An in situ hybridization and receptor-binding study
9. Genesis of the primate neostriatum: (3H)thymidine autoradiographic analysis of the time of neuron origin in the rhesus monkey
10. Neurogenesis of the nucleus accumbens septi and neihboring septal nuclei in the rhesus monkey: A combined (3H)thymidine and electron microcopic study
11. The substantia nigra of the human brain: I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry
12. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
13. Ontogeny of the calcium binding protein calbindin D-28k in the rat nervous system
14. Further indication that distinct dopaminergic subsets project to the rat cerebral cortex: Lack of colocalization with neurotensin in the superficial dopaminergic fields of the anterior cingulate, motor, retrosplenial and visual cortices
15. Localization of nigrostriatal, nigrothalamic and nigrotectal neurons in ventricular coordinates in macaques
16. Development of dopaminergic neurons in the human substantia nigra
17. Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon
18. Topography and collateralizatlon of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys
19. Calbindin D-28K in the dopaminergic mesocortical projection of a monkey (Aotus trivirgatus)
20. Sparing of the dopaminergic neurons containing Calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice
21. The striatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems
22. Midbrain dopa minergic cell loss in Parkinson's disease and MPTP-induced Parkinsonism: Sparing of calbindin-D28k-containing cells
23. Melanin tyrosine hydroxylase calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease
24. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia nigra
25. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: Comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity
26. Comparative anatomy of the ventromedial mesencephalic tegmentum m the rat, cat, monkey and human
27. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease
28. Changes in Ca2+-binding proteins in human neurodegenerative disorder
29. Expression of Calbindin D28k-like immunoreactivity in catecholaminergic cell groups of the human midbrain: Normal distribution and distribution in Parkinson's disease
30. Calbindin-D28K: A potential neuroprotective protein
31. Calretinin-immunoreactive dopaminergic neurons from embryonic rat mesencephalon are resistant to levodopa-induced neurotoxicity
32. Neurogenesis of the amygdaloid nuclear complex in the rhesus monkey
33. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys
34. Transient patterns of calbindin-D28k expression in the developing striatum of man
35. The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey
36. Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurophysiological observations in two patients with putaminal implants
37. Multiple-reaction cycling: A method for enhancement of the immunochemical signal of monoclonal antibodies
38. Transient calbindin-D28K-positive systems in the telencephalon: Ganglionic eminence, developing striatum and cerebral cortex
39. Calbindin D28k-containing neurons are restricted to the medial substantia nigra in humans
40. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans
41. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
42. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: A triple-labeling immunocytochemical study
43. Development of the lateral maygdaloid nucleus in the human brain: Transient presence of discrete cytoarchitectonic units
44. Topography of the monoamine neuron systems in the human brain as revealed in fetuses
45. Horizons de Streeter et age embryonnaire
46. Histochemical demonstration and mapping of 5-hydroxytryptamine-and catecholamine-containing neuron systems in the human fetal brain
47. Cytoarchitecture of the human brain
48. The time coarse of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra
49. Appearance of tyrosine hydroxylase immunoreactivity in the human embryo
50. Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase
51. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon
52. Immunocytochemical localization of tyrosine hydroxylase in the human fetal nervous system
53. Poly- and monoclonal antibodies against recombinant rat brain calbindin D-28K were produced to map the selective distribution in the central nervous system
54. Early neuromeric distribution of tyrosine-immunoreactive neurons in human embryos
55. Neurons in the rhesus monkey visual cortex: Systematic relation between the time or origin and eventual disposition
56. Immunocytochemical markers in rat brain: Colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase
57. Characterization of a polyclonal antiserum against the purified recombinant calcium-binding protein calretinin
58. The human substantia nigra and ventral tegmental area
59. Early evidence of catecholaminergic cell groups in 5- and 6-old human embryos using tyrosine-hydroxylase immunocytochemistry
60. Expression of calbindin (CaBP) in human mesencephalic dopaminergic cells (A8-A9-A10) from the 4th embryonic week on: Immunocytochemistry of tyrosine hydroxylase and calbindine
61. Immunocytochemical evidence of well-developed dopaminergic and noradrenergic innervations in the frontal cerebral cortex of human fetuses at midgestation
62. Structure of longitudinal brain zones that provide the origin for the substantia nigra and ventral tegmental area in human embryos, as revealed by cytoarchitecture and tyrosine hydroxylase, calbindin, calretinin, and GABA immunoreactions
63. Bovine adrenal tyrosine hydroxylase: Comparative study of native and proteolysed enzyme and their interaction with anions
64. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat
65. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28k
66. Development of the catecholamine neurons in human embryos and fetuses, with special emphasis on the innervation of the cerebral cortex